Gorilla and King Portfolio Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Seeker of Truth who wrote (11789)	12/2/1999 4:12:00 PM
From: MulhollandDrive	Read Replies (4) of 54805

Actually there are a number of corporations funding research in gene therapy and the company I mentioned has a very large portfolio of patents. According to the company report on medical patents it says: >>The issuing of patents for genes for medical uses has been common practice for many years. A patent does not grant any right to a gene in its natural state. However, a patent can protect a gene, as the basis of an invention, from commercial exploitation by others. Several patents on human genes now protect products that are comprised of human proteins, such as growth hormone, insulin, and clotting factors.<< It seems to me that there is an incredible potential for proprietary pharmaceuticals and diagnostic methods that can be tapped as the human gene (and other organisms) is mapped. I'm not a medical person, (that's why I posted my query to Stan) but I'm convinced that if the genome mapping produces the kinds of treatments that can literally make our present chemical mode of treating illnesses virtually obsolete, somebody stands to make a tremendous amount of money. bp

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next